Education
Ph.D. in Biochemistry, Free University (FU) of Berlin, Germany, 2013
Current position
Postdoctoral scientist and Deputy group leader in the group of Prof. Dr. W-H. Zimmermann/Dr. L. Zelarayán, Institute of Pharmacology, University Medical Center Göttingen (UMG), Göttingen, Germany
Publications
-
Zafiriou, M. P., Noack, C., Unsold, B., Didie, M., Pavlova, E., Fischer, H. J., Reichardt, H. M., Bergmann, M. W., El-Armouche, A., Zimmermann, W. H. and Zelarayan, L. C. (2014). Erythropoietin responsive cardiomyogenic cells contribute to heart repair post myocardial infarction. Stem Cells 32(9): 2480-2491.
-
Renger, A., Zafiriou, M. P., Noack, C., Pavlova, E., Becker, A., Sharkova, K., Bergmann, M. W., El-Armouche, A., Zimmermann, W. H. and Zelarayan, L. C. (2013). The four and a half LIM-domain 2 controls early cardiac cell commitment and expansion via regulating beta-catenin-dependent transcription. Stem Cells 31(5): 928-940.
-
Noack, C., Zafiriou, M. P., Schaeffer, H. J., Renger, A., Pavlova, E., Dietz, R., Zimmermann, W. H., Bergmann, M. W. and Zelarayan, L. C. (2012). Krueppel-like factor 15 regulates Wnt/beta-catenin transcription and controls cardiac progenitor cell fate in the postnatal heart. EMBO Mol Med 4(9): 992-1007.
-
Zafiriou, M. P., Zelarayan, L. C., Noack, C., Renger, A., Nigam, S. and Siafaka-Kapadai, A. (2011). Hepoxilin A(3) protects beta-cells from apoptosis in contrast to its precursor, 12-hydroperoxyeicosatetraenoic acid. Biochim Biophys Acta 1811(6): 361-369.
-
Christian, F., Szaszak, M., Friedl, S., Drewianka, S., Lorenz, D., Goncalves, A., Furkert, J., Vargas, C., Schmieder, P., Gotz, F., Zuhlke, K., Moutty, M., Gottert, H., Joshi, M., Reif, B., Haase, H., Morano, I., Grossmann, S., Klukovits, A., Verli, J., Gaspar, R., Noack, C., Bergmann, M., Kass, R., Hampel, K., Kashin, D., Genieser, H. G., Herberg, F. W., Willoughby, D., Cooper, D. M., Baillie, G. S., Houslay, M. D., von Kries, J. P., Zimmermann, B., Rosenthal, W. and Klussmann, E. (2011). Small molecule AKAP-protein kinase A (PKA) interaction disruptors that activate PKA interfere with compartmentalized cAMP signaling in cardiac myocytes. J Biol Chem 286(11): 9079-9096.
-
Zelarayan, L. C., Noack, C., Zafiriou, M. P., Renger, A. and Bergmann, M. W. (2010). Wnt signaling molecules in left ventricular remodeling: focus on dishevelled 1. Hypertension 55(4): 852-854.
-
Zelarayan, L., Renger, A., Noack, C., Zafiriou, M. P., Gehrke, C., van der Nagel, R., Dietz, R., de Windt, L. and Bergmann, M. W. (2009). NF-kappaB activation is required for adaptive cardiac hypertrophy. Cardiovasc Res 84(3): 416-424.
-
Zelarayan, L. C., Noack, C., Sekkali, B., Kmecova, J., Gehrke, C., Renger, A., Zafiriou, M. P., van der Nagel, R., Dietz, R., de Windt, L. J., Balligand, J. L. and Bergmann, M. W. (2008). Beta-Catenin downregulation attenuates ischemic cardiac remodeling through enhanced resident precursor cell differentiation. Proc Natl Acad Sci U S A 105(50): 19762-19767.
-
Baurand, A., Zelarayan, L., Betney, R., Gehrke, C., Dunger, S., Noack, C., Busjahn, A., Huelsken, J., Taketo, M. M., Birchmeier, W., Dietz, R. and Bergmann, M. W. (2007). Beta-catenin downregulation is required for adaptive cardiac remodeling. Circ Res 100(9): 1353-1362.